PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,134 | -65.3% | 5,967 | -65.4% | 0.00% | – |
| Q2 2023 | $86,723 | +161.1% | 17,241 | +219.3% | 0.00% | – |
| Q1 2023 | $33,210 | -90.1% | 5,400 | -78.7% | 0.00% | – |
| Q4 2022 | $334,541 | +334.5% | 25,344 | -1.4% | 0.00% | – |
| Q3 2022 | $77,000 | +7600.0% | 25,714 | +15390.4% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 166 | +9.2% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 152 | +3.4% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 147 | +19.5% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 123 | -0.8% | 0.00% | – |
| Q1 2021 | $1,000 | – | 124 | -0.8% | 0.00% | – |
| Q4 2020 | $0 | – | 125 | +68.9% | 0.00% | – |
| Q3 2020 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 74 | -1.3% | 0.00% | – |
| Q1 2020 | $0 | – | 75 | +3650.0% | 0.00% | – |
| Q4 2019 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |